Publicacións (12) Publicacións de María Guillán Fresco

2024

  1. The Hepatokine RBP4 Links Metabolic Diseases to Articular Inflammation

    Antioxidants, Vol. 13, Núm. 1

2023

  1. Formononetin, a Beer Polyphenol with Catabolic Effects on Chondrocytes

    Nutrients, Vol. 15, Núm. 13

  2. Improved Protocol to Study Osteoblast and Adipocyte Differentiation Balance

    Biomedicines, Vol. 11, Núm. 1

  3. Methylphenidate Promotes Premature Growth Plate Closure: In Vitro Evidence

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  4. β Boswellic Acid Blocks Articular Innate Immune Responses: An In Silico and In Vitro Approach to Traditional Medicine

    Antioxidants, Vol. 12, Núm. 2

2022

  1. Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout

    British Journal of Pharmacology, Vol. 179, Núm. 2, pp. 270-286

  2. Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells

    Biomedicine and Pharmacotherapy, Vol. 155

2020

  1. Caffeine, a risk factor for osteoarthritis and longitudinal bone growth inhibition

    Journal of Clinical Medicine, Vol. 9, Núm. 4

2019

  1. Commercially available antibiotic-laden PMMA-covered locking nails for the treatment of fracture-related infections - A retrospective case analysis of 10 cases

    Journal of Bone and Joint Infection, Vol. 4, Núm. 4, pp. 155-162

  2. Visfatin as a therapeutic target for rheumatoid arthritis

    Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 7, pp. 607-618

  3. Visfatin connection: Present and future in osteoarthritis and osteoporosis

    Journal of Clinical Medicine, Vol. 8, Núm. 8

2018

  1. Role of toll-like receptor 4 on osteoblast metabolism and function

    Frontiers in Physiology, Vol. 9, Núm. MAY